Stocks and Investing Stocks and Investing
Thu, October 19, 2023

Vamil Divan Reiterated (ANIP) at Strong Buy and Held Target at $72 on, Oct 19th, 2023


Published on 2024-10-28 06:57:48 - WOPRAI, Vamil Divan
  Print publication without navigation


Vamil Divan of Guggenheim, Reiterated "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy and Held Target at $72 on, Oct 19th, 2023.

Vamil has made no other calls on ANIP in the last 4 months.



There are 2 other peers that have a rating on ANIP. Out of the 2 peers that are also analyzing ANIP, 0 agree with Vamil's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vamil


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $73 on, Tuesday, August 22nd, 2023
  • Gregory Fraser of "Truist Securities" Reiterated at Strong Buy and Held Target at $70 on, Monday, August 21st, 2023

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com